NKTR
Price
$29.68
Change
+$0.56 (+1.92%)
Updated
Jun 26 closing price
Capitalization
368.24M
41 days until earnings call
RXRX
Price
$5.40
Change
+$0.24 (+4.65%)
Updated
Jun 26 closing price
Capitalization
2.2B
46 days until earnings call
Interact to see
Advertisement

NKTR vs RXRX

Header iconNKTR vs RXRX Comparison
Open Charts NKTR vs RXRXBanner chart's image
Nektar Therapeutics
Price$29.68
Change+$0.56 (+1.92%)
Volume$7.04M
Capitalization368.24M
Recursion Pharmaceuticals
Price$5.40
Change+$0.24 (+4.65%)
Volume$21.51M
Capitalization2.2B
NKTR vs RXRX Comparison Chart in %
Loading...
NKTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NKTR vs. RXRX commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NKTR is a Buy and RXRX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (NKTR: $29.68 vs. RXRX: $5.40)
Brand notoriety: NKTR: Notable vs. RXRX: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NKTR: 397% vs. RXRX: 88%
Market capitalization -- NKTR: $368.24M vs. RXRX: $2.2B
NKTR [@Biotechnology] is valued at $368.24M. RXRX’s [@Biotechnology] market capitalization is $2.2B. The market cap for tickers in the [@Biotechnology] industry ranges from $301.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NKTR’s FA Score shows that 0 FA rating(s) are green whileRXRX’s FA Score has 0 green FA rating(s).

  • NKTR’s FA Score: 0 green, 5 red.
  • RXRX’s FA Score: 0 green, 5 red.
According to our system of comparison, RXRX is a better buy in the long-term than NKTR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NKTR’s TA Score shows that 6 TA indicator(s) are bullish while RXRX’s TA Score has 6 bullish TA indicator(s).

  • NKTR’s TA Score: 6 bullish, 4 bearish.
  • RXRX’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, RXRX is a better buy in the short-term than NKTR.

Price Growth

NKTR (@Biotechnology) experienced а +244.72% price change this week, while RXRX (@Biotechnology) price change was +5.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.59%. For the same industry, the average monthly price growth was +34.25%, and the average quarterly price growth was +14.95%.

Reported Earning Dates

NKTR is expected to report earnings on Aug 07, 2025.

RXRX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+3.59% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($2.2B) has a higher market cap than NKTR($368M). NKTR YTD gains are higher at: 112.760 vs. RXRX (-20.118). NKTR has higher annual earnings (EBITDA): -97.97M vs. RXRX (-524.77M). RXRX has more cash in the bank: 500M vs. NKTR (219M). RXRX has less debt than NKTR: RXRX (92.9M) vs NKTR (100M). NKTR has higher revenues than RXRX: NKTR (87.2M) vs RXRX (59.8M).
NKTRRXRXNKTR / RXRX
Capitalization368M2.2B17%
EBITDA-97.97M-524.77M19%
Gain YTD112.760-20.118-560%
P/E RatioN/AN/A-
Revenue87.2M59.8M146%
Total Cash219M500M44%
Total Debt100M92.9M108%
FUNDAMENTALS RATINGS
NKTR: Fundamental Ratings
NKTR
OUTLOOK RATING
1..100
96
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
84
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NKTRRXRX
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
86%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 24 days ago
84%
Declines
ODDS (%)
Bearish Trend 8 days ago
89%
Bearish Trend 5 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
Aroon
ODDS (%)
Bullish Trend 1 day ago
69%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
NKTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RLNCX48.210.52
+1.09%
Russell Inv International Devd Mkts C
FBCIX75.830.54
+0.72%
American Funds Capital Income Bldr 529F2
BOPAX24.78N/A
N/A
Sterling Capital Special Opps A
MIDKX23.72N/A
N/A
Shelton S&P Midcap Index K
FVFRX53.12N/A
N/A
Franklin Small Cap Value R

RXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been closely correlated with CRSP. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if RXRX jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
+4.65%
CRSP - RXRX
72%
Closely correlated
-0.17%
BEAM - RXRX
64%
Loosely correlated
+2.27%
ABSI - RXRX
62%
Loosely correlated
-1.81%
ABCL - RXRX
59%
Loosely correlated
-1.58%
PRME - RXRX
57%
Loosely correlated
+9.50%
More